XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Deficit
Accumulated other comprehensive income
Total shareholders' equity
Non-controlling interests
Beginning balance ( in shares) at Dec. 31, 2018   91,445,066        
Beginning balance at Dec. 31, 2018 $ 144,854 $ 469,303 $ (332,058) $ 3,843 $ 141,088 $ 3,766
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (12,134)   (12,127)   (12,127) (7)
Other comprehensive loss (136)     (136) (136)  
Shares issued for cash by at-the-market offering (in shares)   754,712        
Shares issued for cash by at-the-market offering 2,471 $ 2,471     2,471  
Share issuance cost (62) (62)     (62)  
Share-based compensation 1,121 $ 1,121     1,121  
shares issued for exrcise of stock options (in shares)   33,906        
Shares issued for exercise of stock options 102 $ 102     102  
Shares issued for the vesting of restricted stock units (in shares)   850,150        
Shares issued for consulting services (in shares)   18,848        
Ending balance (in shares) at Mar. 31, 2019   93,102,682        
Ending balance at Mar. 31, 2019 136,268 $ 472,987 (344,185) 3,707 132,509 3,759
Beginning balance ( in shares) at Dec. 31, 2018   91,445,066        
Beginning balance at Dec. 31, 2018 144,854 $ 469,303 (332,058) 3,843 141,088 3,766
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (21,448)          
Other comprehensive loss (907)          
Ending balance (in shares) at Jun. 30, 2019   95,551,357        
Ending balance at Jun. 30, 2019 134,295 $ 481,053 (353,497) 2,936 130,492 3,803
Beginning balance ( in shares) at Mar. 31, 2019   93,102,682        
Beginning balance at Mar. 31, 2019 136,268 $ 472,987 (344,185) 3,707 132,509 3,759
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (9,314)   (9,312)   (9,312) (2)
Other comprehensive loss (771)     (771) (771)  
Shares issued for cash by at-the-market offering (in shares)   2,141,817        
Shares issued for cash by at-the-market offering 6,595 $ 6,595     6,595  
Shares issued to settle liabilities (in shares)   266,272        
Shares issued to settle liabilities 847 $ 847     847  
Share issuance cost (151) (151)     (151)  
Share-based compensation 663 $ 663     663  
shares issued for exrcise of stock options (in shares)   20,899        
Shares issued for exercise of stock options 44 $ 44     44  
Shares issued for exercise of warrants (in shares)   1,450        
Shares issued for exercise of warrants 5 $ 5     5  
Shares issued for consulting services (in shares)   18,237        
Shares issued for consulting services 63 $ 63     63  
Contributions attributable to non-controlling interest 46         46
Ending balance (in shares) at Jun. 30, 2019   95,551,357        
Ending balance at Jun. 30, 2019 134,295 $ 481,053 (353,497) 2,936 130,492 3,803
Beginning balance ( in shares) at Dec. 31, 2019   100,735,889        
Beginning balance at Dec. 31, 2019 130,607 $ 493,958 (370,036) 2,989 126,911 3,696
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (5,664)   (5,657)   (5,657) (7)
Other comprehensive loss 152     152 152  
Shares issued for cash by at-the-market offering (in shares)   13,688,815        
Shares issued for cash by at-the-market offering 20,658 $ 20,658     20,658  
Share issuance cost (1,563) (1,563)     (1,563)  
Share-based compensation 997 $ 997     997  
Shares issued for the vesting of restricted stock units (in shares)   490,453        
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (415) $ (415)     (415)  
Shares issued for consulting services (in shares)   30,000        
Shares issued for consulting services 57 $ 57     57  
Contributions attributable to non-controlling interest 133         133
Ending balance (in shares) at Mar. 31, 2020   114,945,157        
Ending balance at Mar. 31, 2020 144,962 $ 513,692 (375,693) 3,141 141,140 3,822
Beginning balance ( in shares) at Dec. 31, 2019   100,735,889        
Beginning balance at Dec. 31, 2019 130,607 $ 493,958 (370,036) 2,989 126,911 3,696
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (13,854)          
Other comprehensive loss (227)          
Ending balance (in shares) at Jun. 30, 2020   120,534,705        
Ending balance at Jun. 30, 2020 145,897 $ 523,196 (383,880) 2,762 142,078 3,819
Beginning balance ( in shares) at Mar. 31, 2020   114,945,157        
Beginning balance at Mar. 31, 2020 144,962 $ 513,692 (375,693) 3,141 141,140 3,822
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (8,190)   (8,187)   (8,187) (3)
Other comprehensive loss (379)     (379) (379)  
Shares issued for cash by at-the-market offering (in shares)   5,559,548        
Shares issued for cash by at-the-market offering 8,969 $ 8,969     8,969  
Share issuance cost (202) (202)     (202)  
Share-based compensation 704 $ 704     704  
Shares issued for consulting services (in shares)   30,000        
Shares issued for consulting services 33 $ 33     33  
Ending balance (in shares) at Jun. 30, 2020   120,534,705        
Ending balance at Jun. 30, 2020 $ 145,897 $ 523,196 $ (383,880) $ 2,762 $ 142,078 $ 3,819